Cargando…
Screening and identification of a CD44v6 specific peptide using improved phage display for gastric cancer targeting
BACKGROUND: Peptide probes can be applied for biomarker targeting to improve the diagnostic accuracy. Cluster of differentiation 44 (CD44) is up-regulated in gastric cancer (GC). Among all the variants of CD44, CD44v6 is reported the most promising biomarker for GC. The purpose of this study was gen...
Autores principales: | Zhang, Dan, Huang, Jin, Li, Weiming, Zhang, Zhiyong, Zhu, Meng, Feng, Yun, Zhao, Yan, Li, Yarui, Lu, Shaoying, He, Shuixiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723568/ https://www.ncbi.nlm.nih.gov/pubmed/33313187 http://dx.doi.org/10.21037/atm-19-4781 |
Ejemplares similares
-
A CD44-specific peptide, RP-1, exhibits capacities of assisting diagnosis and predicting prognosis of gastric cancer
por: Li, Weiming, et al.
Publicado: (2017) -
Targeting aggressive prostate cancer-associated CD44v6 using phage display selected peptides
por: Peng, Ying, et al.
Publicado: (2017) -
Screening and Identification of Peptides Specifically Targeted to Gastric Cancer Cells from a Phage Display Peptide Library
por: Sahin, Deniz, et al.
Publicado: (2018) -
The Screening of Therapeutic Peptides for Anti-Inflammation through Phage Display Technology
por: Zhang, Kangran, et al.
Publicado: (2022) -
Identification of gliadin-binding peptides by phage display
por: Chen, Tingsu, et al.
Publicado: (2011)